Skip to Main Content

Paper Details

The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer.
JCI Insight
28
2021
ERBB2, HER2, HER2+, HER2+ breast cancer, Lyve1, PI3K catalytic subunit, PIK3CA, PIK3CA gene, alveolar epithelial and fibroblastic reticular cells, breast cancer, cells, human, human epidermal growth factor receptor 2, lymphatic vessel endothelial hyaluronan receptor 1, patient, patient-derived xenograft models, tumor, tumor epithelial cells
Author NameAffiliation
Elisabetta MarangoniInstitut Curie
Simona CristeaDana-Farber Cancer Institute
Simona CristeaHarvard T.H. Chan School of Public Health
Simona CristeaHarvard University
Eric P WinerDana-Farber Cancer Institute
Eric P WinerBrigham and Women's Hospital, Harvard Medical School
Ian E KropDana-Farber Cancer Institute
Paul T SpellmanOHSU Knight Cancer Institute, Oregon Health and Science University
Paul T SpellmanOregon Health and Science University
Paul T SpellmanOHSU Knight Cancer Institute, Oregon Health and Science University
Paul T SpellmanOregon Health and Science University
Elmar BucherOHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University
Elmar BucherOHSU Knight Cancer Institute, Oregon Health and Science University
Joe W GrayOHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University
Joe W GrayOHSU Knight Cancer Institute, Oregon Health and Science University
Joe W GrayOHSU Center for Spatial Systems Biomedicine, Oregon Health and Science University
Joe W GrayOHSU Knight Cancer Institute, Oregon Health and Science University
Kornelia PolyakDana-Farber Cancer Institute
Kornelia PolyakBrigham and Women's Hospital, Harvard Medical School
Kornelia PolyakCenter for Cancer Evolution, Dana-Farber Cancer Institute
Kornelia PolyakThe Broad Institute of MIT and Harvard
Kornelia PolyakLudwig Center at Harvard Medical School
Kornelia PolyakDana-Farber Cancer Institute
Kornelia PolyakBrigham and Women's Hospital, Harvard Medical School
Kornelia PolyakCenter for Cancer Evolution, Dana-Farber Cancer Institute
Kornelia PolyakThe Broad Institute of MIT and Harvard
Kornelia PolyakLudwig Center at Harvard Medical School
  • 1 - 27

Datasets